SOTERA HEALTH CO (SHC) Stock Fundamental Analysis

NASDAQ:SHC • US83601L1026

16.97 USD
-0.4 (-2.3%)
At close: Feb 12, 2026
16.97 USD
0 (0%)
After Hours: 2/12/2026, 8:15:44 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Overall SHC gets a fundamental rating of 4 out of 10. We evaluated SHC against 58 industry peers in the Life Sciences Tools & Services industry. SHC scores excellent on profitability, but there are concerns on its financial health. SHC has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year SHC was profitable.
  • In the past year SHC had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: SHC reported negative net income in multiple years.
  • SHC had a positive operating cash flow in 4 of the past 5 years.
SHC Yearly Net Income VS EBIT VS OCF VS FCFSHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

  • SHC's Return On Assets of 1.74% is fine compared to the rest of the industry. SHC outperforms 70.69% of its industry peers.
  • Looking at the Return On Equity, with a value of 10.07%, SHC belongs to the top of the industry, outperforming 81.03% of the companies in the same industry.
  • SHC has a better Return On Invested Capital (9.23%) than 84.48% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for SHC is below the industry average of 12.42%.
  • The last Return On Invested Capital (9.23%) for SHC is above the 3 year average (8.04%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.74%
ROE 10.07%
ROIC 9.23%
ROA(3y)-1.47%
ROA(5y)-0.34%
ROE(3y)-14.75%
ROE(5y)-6.62%
ROIC(3y)8.04%
ROIC(5y)7.61%
SHC Yearly ROA, ROE, ROICSHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

  • With a decent Profit Margin value of 4.82%, SHC is doing good in the industry, outperforming 72.41% of the companies in the same industry.
  • SHC's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 29.89%, SHC belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of SHC has grown nicely.
  • The Gross Margin of SHC (55.98%) is better than 70.69% of its industry peers.
  • In the last couple of years the Gross Margin of SHC has grown nicely.
Industry RankSector Rank
OM 29.89%
PM (TTM) 4.82%
GM 55.98%
OM growth 3Y-0.64%
OM growth 5Y2.13%
PM growth 3Y-31.23%
PM growth 5YN/A
GM growth 3Y-0.57%
GM growth 5Y1.5%
SHC Yearly Profit, Operating, Gross MarginsSHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SHC is destroying value.
  • The number of shares outstanding for SHC has been increased compared to 1 year ago.
  • SHC has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, SHC has a worse debt to assets ratio.
SHC Yearly Shares OutstandingSHC Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
SHC Yearly Total Debt VS Total AssetsSHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • SHC has an Altman-Z score of 1.69. This is a bad value and indicates that SHC is not financially healthy and even has some risk of bankruptcy.
  • SHC's Altman-Z score of 1.69 is in line compared to the rest of the industry. SHC outperforms 55.17% of its industry peers.
  • SHC has a debt to FCF ratio of 25.87. This is a negative value and a sign of low solvency as SHC would need 25.87 years to pay back of all of its debts.
  • SHC has a Debt to FCF ratio of 25.87. This is comparable to the rest of the industry: SHC outperforms 56.90% of its industry peers.
  • A Debt/Equity ratio of 4.04 is on the high side and indicates that SHC has dependencies on debt financing.
  • SHC's Debt to Equity ratio of 4.04 is on the low side compared to the rest of the industry. SHC is outperformed by 91.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.04
Debt/FCF 25.87
Altman-Z 1.69
ROIC/WACC0.83
WACC11.13%
SHC Yearly LT Debt VS Equity VS FCFSHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

  • A Current Ratio of 2.38 indicates that SHC has no problem at all paying its short term obligations.
  • SHC has a Current ratio of 2.38. This is comparable to the rest of the industry: SHC outperforms 46.55% of its industry peers.
  • SHC has a Quick Ratio of 2.16. This indicates that SHC is financially healthy and has no problem in meeting its short term obligations.
  • SHC has a Quick ratio (2.16) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.38
Quick Ratio 2.16
SHC Yearly Current Assets VS Current LiabilitesSHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • SHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.00%, which is quite good.
  • The Earnings Per Share has been decreasing by -7.34% on average over the past years.
  • The Revenue for SHC has decreased by -15.95% in the past year. This is quite bad
  • The Revenue has been growing slightly by 7.17% on average over the past years.
EPS 1Y (TTM)8%
EPS 3Y-7.34%
EPS 5YN/A
EPS Q2Q%52.94%
Revenue 1Y (TTM)-15.95%
Revenue growth 3Y5.71%
Revenue growth 5Y7.17%
Sales Q2Q%9.05%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.65% on average over the next years. This is quite good.
  • SHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.85% yearly.
EPS Next Y20.93%
EPS Next 2Y16.36%
EPS Next 3Y14.51%
EPS Next 5Y15.65%
Revenue Next Year5.31%
Revenue Next 2Y5.6%
Revenue Next 3Y5.78%
Revenue Next 5Y6.85%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SHC Yearly Revenue VS EstimatesSHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
SHC Yearly EPS VS EstimatesSHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 20.95, SHC is valued on the expensive side.
  • Based on the Price/Earnings ratio, SHC is valued cheaply inside the industry as 81.03% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of SHC to the average of the S&P500 Index (27.67), we can say SHC is valued slightly cheaper.
  • The Price/Forward Earnings ratio is 17.90, which indicates a rather expensive current valuation of SHC.
  • Based on the Price/Forward Earnings ratio, SHC is valued cheaper than 84.48% of the companies in the same industry.
  • SHC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.69.
Industry RankSector Rank
PE 20.95
Fwd PE 17.9
SHC Price Earnings VS Forward Price EarningsSHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SHC is valued cheaper than 89.66% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SHC is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 55.66
EV/EBITDA 13.85
SHC Per share dataSHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • SHC's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of SHC may justify a higher PE ratio.
  • SHC's earnings are expected to grow with 14.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)1
PEG (5Y)N/A
EPS Next 2Y16.36%
EPS Next 3Y14.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • SHC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SOTERA HEALTH CO

NASDAQ:SHC (2/12/2026, 8:15:44 PM)

After market: 16.97 0 (0%)

16.97

-0.4 (-2.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-04
Earnings (Next)03-03
Inst Owners58.12%
Inst Owner Change1.66%
Ins Owners2.34%
Ins Owner Change-14.04%
Market Cap4.82B
Revenue(TTM)1.15B
Net Income(TTM)55.42M
Analysts82.86
Price Target20.85 (22.86%)
Short Float %3.14%
Short Ratio3.08
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.17%
Min EPS beat(2)14.56%
Max EPS beat(2)17.78%
EPS beat(4)4
Avg EPS beat(4)12.29%
Min EPS beat(4)3.1%
Max EPS beat(4)17.78%
EPS beat(8)6
Avg EPS beat(8)7.28%
EPS beat(12)9
Avg EPS beat(12)7.47%
EPS beat(16)13
Avg EPS beat(16)7.3%
Revenue beat(2)2
Avg Revenue beat(2)3.57%
Min Revenue beat(2)1.52%
Max Revenue beat(2)5.63%
Revenue beat(4)3
Avg Revenue beat(4)2.11%
Min Revenue beat(4)-1.22%
Max Revenue beat(4)5.63%
Revenue beat(8)6
Avg Revenue beat(8)0.06%
Revenue beat(12)7
Avg Revenue beat(12)-0.33%
Revenue beat(16)10
Avg Revenue beat(16)0.07%
PT rev (1m)7.97%
PT rev (3m)17.12%
EPS NQ rev (1m)0.34%
EPS NQ rev (3m)0.62%
EPS NY rev (1m)0.29%
EPS NY rev (3m)6.61%
Revenue NQ rev (1m)0.18%
Revenue NQ rev (3m)-0.1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.17%
Valuation
Industry RankSector Rank
PE 20.95
Fwd PE 17.9
P/S 4.19
P/FCF 55.66
P/OCF 20.1
P/B 8.76
P/tB N/A
EV/EBITDA 13.85
EPS(TTM)0.81
EY4.77%
EPS(NY)0.95
Fwd EY5.59%
FCF(TTM)0.3
FCFY1.8%
OCF(TTM)0.84
OCFY4.97%
SpS4.05
BVpS1.94
TBVpS-2.93
PEG (NY)1
PEG (5Y)N/A
Graham Number5.94
Profitability
Industry RankSector Rank
ROA 1.74%
ROE 10.07%
ROCE 11.68%
ROIC 9.23%
ROICexc 10.27%
ROICexgc 21.53%
OM 29.89%
PM (TTM) 4.82%
GM 55.98%
FCFM 7.53%
ROA(3y)-1.47%
ROA(5y)-0.34%
ROE(3y)-14.75%
ROE(5y)-6.62%
ROIC(3y)8.04%
ROIC(5y)7.61%
ROICexc(3y)9.2%
ROICexc(5y)8.42%
ROICexgc(3y)32.15%
ROICexgc(5y)28.54%
ROCE(3y)10.18%
ROCE(5y)9.64%
ROICexgc growth 3Y-8.13%
ROICexgc growth 5Y-2.77%
ROICexc growth 3Y3.93%
ROICexc growth 5Y7.64%
OM growth 3Y-0.64%
OM growth 5Y2.13%
PM growth 3Y-31.23%
PM growth 5YN/A
GM growth 3Y-0.57%
GM growth 5Y1.5%
F-Score5
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 4.04
Debt/FCF 25.87
Debt/EBITDA 4.55
Cap/Depr 106.02%
Cap/Sales 13.32%
Interest Coverage 2.06
Cash Conversion 49.11%
Profit Quality 156.3%
Current Ratio 2.38
Quick Ratio 2.16
Altman-Z 1.69
F-Score5
WACC11.13%
ROIC/WACC0.83
Cap/Depr(3y)123.61%
Cap/Depr(5y)95.16%
Cap/Sales(3y)18.31%
Cap/Sales(5y)14.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8%
EPS 3Y-7.34%
EPS 5YN/A
EPS Q2Q%52.94%
EPS Next Y20.93%
EPS Next 2Y16.36%
EPS Next 3Y14.51%
EPS Next 5Y15.65%
Revenue 1Y (TTM)-15.95%
Revenue growth 3Y5.71%
Revenue growth 5Y7.17%
Sales Q2Q%9.05%
Revenue Next Year5.31%
Revenue Next 2Y5.6%
Revenue Next 3Y5.78%
Revenue Next 5Y6.85%
EBIT growth 1Y-6.5%
EBIT growth 3Y5.04%
EBIT growth 5Y9.46%
EBIT Next Year29.61%
EBIT Next 3Y13.68%
EBIT Next 5Y12.3%
FCF growth 1Y122.75%
FCF growth 3Y-36.88%
FCF growth 5Y-13.23%
OCF growth 1Y250.92%
OCF growth 3Y-7.31%
OCF growth 5Y8.51%

SOTERA HEALTH CO / SHC FAQ

What is the fundamental rating for SHC stock?

ChartMill assigns a fundamental rating of 4 / 10 to SHC.


What is the valuation status of SOTERA HEALTH CO (SHC) stock?

ChartMill assigns a valuation rating of 5 / 10 to SOTERA HEALTH CO (SHC). This can be considered as Fairly Valued.


What is the profitability of SHC stock?

SOTERA HEALTH CO (SHC) has a profitability rating of 7 / 10.


How financially healthy is SOTERA HEALTH CO?

The financial health rating of SOTERA HEALTH CO (SHC) is 3 / 10.